CLAIM #12095 · Bristol-Myers Squibb Company (BMY) · 2024Q4 earnings call · Feb 6, 2025 · due Dec 31, 2030
“Specifically, that means increasing the velocity of growth that we have in the last couple of years exiting this decade and into the next.”
Chris Boerner · CEO
PENDING
graded after results covering Dec 31, 2030 are reported
How to check this claim
Look at: Company revenue growth rate (year-over-year), as reported
It came true if: Revenue growth rate in years approaching and entering the 2030s exceeds the average annual growth rate of the preceding couple of years (i.e., growth accelerates rather than staying flat or declining)
Where: Company income statement / annual report (10-K) revenue figures
Verify independently
SEC filings for BMY ↗ · Claim quote is verbatim from the 2024Q4 earnings call.